Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873793 | 0.98 | TSHR (0.33) | TSHRNPSR1 | |
| SCHEMBL10760706 | 0.72 | TSHR (0.32) | TSHRNPSR1 | |
| SCHEMBL3255645 | 0.67 | — | — | |
| Sulfuric Acid SCHEMBL27857454 | 0.65 | TSHR (0.41) | TSHRNPSR1 | |
| SCHEMBL3263772 | 0.65 | TSHR (0.32) | TSHRNPSR1 | |
| Ethylene SCHEMBL4351883 | 0.64 | TSHR (0.38) | TSHRNPSR1 | |
| SCHEMBL9479023 | 0.63 | BACE1 (0.41) | TSHR | |
| Bicarbonate SCHEMBL9560500 | 0.62 | TSHR (0.37) | TSHRNPSR1 | |
| SCHEMBL13805603 | 0.61 | TSHR (0.44) | TSHRNPSR1 | |
| Oxalic Acid SCHEMBL9221357 | 0.60 | TSHR (0.35) | TSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1355 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4684872-A1 | DEVICE AND METHOD FOR WATER-IN-AIR GENERATION OF DROPLETS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-01-28 | — | — | EP | claimed |
| US-12350352-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2025-07-08 | — | — | US | claimed |
| EP-4100001-B1 | CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF | I MED S COOP (ES) | 2025-06-25 | — | — | EP | claimed |
| US-12298310-B2 | Methods for cancer detection with quantum dots | DREXEL UNIVERSITY (US) | 2025-05-13 | — | — | US | claimed |
| US-12153051-B2 | Reagents for quantitative mass spectrometry | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-11-26 | — | — | US | claimed |
| US-20240272167-A1 | REAGENTS FOR QUANTITATIVE MASS SPECTROMETRY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-08-15 | — | — | US | claimed |
| EP-3342395-B1 | COMPOSITION FOR HAIR SURFACE MODIFICATION | LG HOUSEHOLD & HEALTH CARE LTD (KR) | 2024-08-07 | — | — | EP | claimed |
| EP-4406617-A2 | COMPOSITION FOR SURFACE MODIFICATION | LG Household & Health Care Ltd. (KR) | 2024-07-31 | — | — | EP | claimed |
| EP-4380962-A1 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | MSN Laboratories Private Limited, R&D Center (IN) | 2024-06-12 | — | — | EP | claimed |
| EP-4381088-A1 | SYSTEMS AND METHODS FOR ANTIBODY CHAIN PAIRING | Rapid Novor Inc. (CA) | 2024-06-12 | — | — | EP | claimed |
| US-5986066-A | BIOMOLECULAR COATING ON SURFACE FOR ANALYZING SENSORY LAYERS SENSORY LAYERS | ROCHE DIAGNOSTICS CORPORATION (US) | 1999-11-16 | — | — | US | claimed |
| WO-1999052561-A1 | INHIBITION OF XENOREACTIVE ANTIBODIES | BAXTER INTERNATIONAL INC. (US) | 1999-10-21 | — | — | WO | claimed |
| WO-1999024074-A2 | NOVEL CONJUGATES OF OPIOIDS AND ENDOGENOUS CARRIERS | CONJUCHEM, INC. (CA) | 1999-05-20 | — | — | WO | claimed |
| CN-1173824-A | Process for the coating of objects with hyaluronic acid, derivatives thereof, and natural and semisynthetic polymers | FIDIA ADVANCED BIOPOLYMERS SRL (IT) | 1998-02-18 | — | — | CN | claimed |
| EP-0808181-A1 | PROCESS FOR THE COATING OF OBJECTS WITH HYALURONIC ACID, DERIVATIVES THEREOF, AND SEMISYNTHETIC POLYMERS | FIDIA ADVANCED BIOPOLYMERS S.R.L. (IT) | 1997-11-26 | — | — | EP | claimed |
| EP-0578145-B1 | Compounds and process for photoactivable labelling of biomolecules | HOFFMANN LA ROCHE (CH) | 1997-10-29 | — | — | EP | claimed |
| WO-1997027885-A1 | PREPARATION OF BIOLOGICAL MATERIAL FOR IMPLANTS | LEE JOHN MICHAEL (CA) | 1997-08-07 | — | — | WO | claimed |
| US-5646302-A | QUATERNARY AZIDOBENZENE SALT COMPOUNDS | ROCHE DIAGNOSTIC SYSTEMS, INC. (US) | 1997-07-08 | — | — | US | claimed |
| WO-1996024392-A1 | PROCESS FOR THE COATING OF OBJECTS WITH HYALURONIC ACID, DERIVATIVES THEREOF, AND SEMISYNTHETIC POLYMERS | FIDIA ADVANCED BIOPOLYMERS, S.R.L. (IT) | 1996-08-15 | — | — | WO | claimed |
| EP-0578145-A1 | Compounds and process for photoactivable labelling of biomolecules | F. HOFFMANN-LA ROCHE AG (CH) | 1994-01-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12153051-B2 | Reagents for quantitative mass spectrometry | CHAMP1, SRMS, QPCTL | TSHR 3110/4885NPSR1 3371/4885 |
| US-12350352-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | TSHR 3020/4885NPSR1 4234/4885 |
| US-20240272167-A1 | REAGENTS FOR QUANTITATIVE MASS SPECTROMETRY | CHAMP1, SRMS, QPCTL | TSHR 3110/4885NPSR1 3371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.